Current Valuation
N/A
As of June 24, 2024
Total Funding Raised
$101.4M
Last Round
Later Stage VC

$71.0M

Last Funding
Jun 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Vico Therapeutics is currently valued at N/A as of June 24, 2024. The company has raised a total of $101.4M in funding.

Investment Perspective

Vico Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Vico Therapeutics Valuation Updates

Get notified when Vico Therapeutics raises new funding or valuation changes

What is Vico Therapeutics Worth in 2025?

As of 2025, Vico Therapeutics is valued at N/A, based on the company's Later Stage VC funding round in June 24, 2024. This valuation positions Vico Therapeutics as one of the leading private companies in the sector.

Vico Therapeutics Valuation History

Vico Therapeutics's funding history demonstrates steady growth and investor confidence.

How Vico Therapeutics Valuation is Determined

Private company valuations like Vico Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Vico Therapeutics Valuation FAQs

Is Vico Therapeutics profitable?

Vico Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Vico Therapeutics's valuation compare to competitors?

Vico Therapeutics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Vico Therapeutics IPO?

Vico Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Vico Therapeutics shares through secondary market platforms.